Weekly Subcutaneous Semaglutide as Adjunct to Closed-loop Therapy in Type 1 Diabetes Care

Clinical trial NCT05205928 · COMPLETED

Trial details

NCT number: NCT05205928
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Type 1 Diabetes Diabetes Mellitus, Type 1

Start date: 2022-10-02
Primary completion: 2024-04-15
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.